[1]AdvancedSynthesisandCatalysis,2005,vol.347,#7-8,p.1027-1034
[1]Patent:CN106854165,2017,A,
[1]JournalofLabelledCompoundsandRadiopharmaceuticals,2001,vol.44,p.S393-S395
[2]Patent:WO2015/51725,2015,A1,.Locationinpatent:Page/Pagecolumn77
[3]Patent:WO2015/73342,2015,A1,.Locationinpatent:Page/Pagecolumn85;86
[1]JournalofOrganicChemistry,1990,vol.55,#2,p.773-775
[2]JournalofOrganicChemistry,1990,vol.55,#2,p.773-775
[1]JournaloftheChemicalSociety-PerkinTransactions1,1996,#7,p.605-609
[1]MonatsheftefurChemie,1959,vol.90,p.683,687
[1]JournalofOrganicChemistry,1990,vol.55,p.773-775
[2]JournalofOrganicChemistry,1990,vol.55,p.773-775
[1]JournalofOrganicChemistry,1990,vol.55,p.2034-2044
[1]ChemicalandPharmaceuticalBulletin,1992,vol.40,p.1047-1049
[2]Patent:US2006/223810,2006,A1.Locationinpatent:Page/Pagecolumn23
[3]Patent:WO2006/21448,2006,A1.Locationinpatent:Page/Pagecolumn59
[4]Patent:US2010/324030,2010,A1.Locationinpatent:Page/Pagecolumn11
[5]Patent:CN108218848,2018,A.Locationinpatent:Paragraph0167-0169
[1]JournalofMedicinalChemistry,2012,vol.55,p.4189-4204
[2]JournalofMedicinalChemistry,1982,vol.25,p.84-86
[3]Patent:CN108947868,2018,A.Locationinpatent:Paragraph0039;0044;0047-0048
[4]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.954-959
[5]JournalofMolecularStructure,2006,vol.788,p.63-71
[6]JournalofMedicinalChemistry,2006,vol.49,p.4512-4516
[7]JournalofFluorineChemistry,2007,vol.128,p.641-646
[8]BioorganicandMedicinalChemistry,2006,vol.14,p.8574-8581
[9]Patent:EP1000059,2004,B1.Locationinpatent:Page33
[10]Patent:US6831079,2004,B1.Locationinpatent:Page/Pagecolumn62
[11]BioorganicandMedicinalChemistryLetters,2010,vol.20,p.3936-3940
[12]Patent:US2012/238587,2012,A1.Locationinpatent:Page/Pagecolumn23
[13]BioorganicandMedicinalChemistry,2013,vol.21,p.2843-2855
[14]ChemicalCommunications,2013,vol.49,p.5313-5315
[15]ArchivderPharmazie,2013,vol.346,p.521-533
[16]Patent:WO2014/28968,2014,A1.Locationinpatent:Page/Pagecolumn100
[17]BioorganicandMedicinalChemistry,2014,vol.22,p.3670-3683
[18]Patent:US2015/266825,2015,A1.Locationinpatent:Paragraph1245;1246
[19]BioorganicandMedicinalChemistry,2016,vol.24,p.2307-2317
[20]OrganicLetters,2016,vol.18,p.5536-5539
[21]BioorganicandMedicinalChemistryLetters,2017,vol.27,p.393-397
[22]EuropeanJournalofMedicinalChemistry,2017,vol.137,p.139-155
[23]Patent:CN106854165,2017,A.Locationinpatent:Paragraph0099;0100;0101;0132;0133
[24]EuropeanJournalofMedicinalChemistry,2018,vol.155,p.197-209
[25]AngewandteChemie-InternationalEdition,2018,vol.57,p.15762-15766 Angew.Chem.,2018,vol.130,p.15988-15992,5
[26]BioorganicChemistry,2020,vol.102
[27]Patent:CN111377934,2020,A.Locationinpatent:Paragraph0333-0335
Title: Structural and spectroscopic characterization of 2,3-difluorobenzoic acid and 2,4-difluorobenzoic acid with experimental techniques and quantum chemical calculations.
Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20110901
Title: 2-(4-Chloro-phen-yl)-2-oxoethyl 2,4-di-fluoro-benzoate.
Journal: Acta crystallographica. Section E, Structure reports online 20110701
Title: Tetra-kis(μ-2,4-difluoro-benzoato)bis-[(2,2'-bipyridine)(2,4-difluoro-benzoato)terbium(III)].
Journal: Acta crystallographica. Section E, Structure reports online 20090201
Title: Tetra-kis(μ-2,4-difluoro-benzoato)bis-[(2,4-difluoro-benzoato)(1,10-phenanthroline)gadolinium(III)].
Journal: Acta crystallographica. Section E, Structure reports online 20080401
Title: Pharmacological evaluation of C-3 modified Betulinic acid derivatives with potent anticancer activity.
Journal: Investigational new drugs 20080201